5,026
Views
47
CrossRef citations to date
0
Altmetric
Original Article

Cardiovascular disease patients have increased risk for comorbidity: A cross-sectional study in the Netherlands

ORCID Icon, , &
Pages 45-50 | Received 15 Nov 2016, Accepted 15 Oct 2017, Published online: 23 Nov 2017

References

  • Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying cause of death 1999–2013 on CDC WONDER online database, released 2015. Data are mult. cause death files. 1999;2013.
  • Leading_causes_of_death_age_group_2015_1050w740h.gif (1050 × 740) [Internet]. 2016 [cited 2017 Apr 25]. Available from: https://www.cdc.gov/injury/images/lc-charts/leading_causes_of_death_age_group_2015_1050w740h.gif
  • Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307–1315.
  • Tripathy JP, Thakur J, Jeet G, et al. Prevalence and determinants of comorbid diabetes and hypertension: evidence from non-communicable disease risk factor STEPS survey, India. Diabetes Metab Syndr Clin Res Rev. 2017;11(S1):S459-S465.
  • Valderas JM, Starfield B, Sibbald B, et al. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7:357–363.
  • Van den Akker M, Buntinx F, Metsemakers JF, et al. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51:367–375.
  • Pati S, Swain S, Hussain MA, et al. Prevalence and outcomes of multimorbidity in South Asia: a systematic review. BMJ Open. 2015;5:e007235.
  • Salisbury C, Johnson L, Purdy S, et al. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61:e12–e21.
  • Farmer C, Fenu E, O’Flynn N, etet al. Clinical assessment and management of multimorbidity: summary of NICE guidance. Br Med J. 2016;354:i4843.
  • Starfield B, Lemke KW, Bernhardt T, et al. Comorbidity: implications for the importance of primary care in ‘case’ management. Ann Fam Med. 2003;1:8–14.
  • Rasputina L, Didenko D. Prevalence of chronic obstructive pulmonary disease in patients with coronary heart disease and arterial hypertension. Eureka. 2017;(2):38–45.
  • Aarts S, van den Akker M, Tan F, et al. Influence of multimorbidity on cognition in a normal aging population: a 12‐year follow‐up in the Maastricht aging study. Int J Geriat Psychiatry. 2011;26:1046–1053.
  • Bang DH, Xu J, Keenan RT, et al. Cardiovascular disease prevalence in patients with osteoarthritis, gout, or both. Bull Hosp Jt Dis. 2016;74:113–118.
  • Zander N, Schäfer I, Radtke M, et al. Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees. Arch Dermatol Res 2017;309:349–356.
  • Landwehr Johan S, Van den Akker M, Metsemakers J, et al. Comorbidity of chronic cardiovascular disorders: a cross-sectional analysis in a large general practice population in the Netherlands. Arch Public Health. 2000;58:213–231.
  • Prados-Torres A, Poblador-Plou B, Calderón-Larrañaga A, et al. Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PloS One. 2012;7:e32190.
  • Metsemakers J, Höppener P, Knottnerus JA, et al. Computerized health information in The Netherlands: a registration network of family practices. Br J Gen Pr. 1992;42:102–106.
  • Explained EuroStat statistics. Population structure and ageing. 2017 [cited 2017 Apr 25]. Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Population_structure_and_ageing
  • Bruce DG, Davis WA, Dragovic M, et al. Comorbid anxiety and depression and their impact on cardiovascular disease in Type 2 diabetes: the Fremantle diabetes study phase II. Depress Anxiety. 2016;33:960–966.
  • Sarfati D, Gurney J, Lim BT, et al. Identifying important comorbidity among cancer populations using administrative data: prevalence and impact on survival. Asia Pac J Clin Oncol. 2016;12:e47–e56.
  • Dursunoglu N, Kokturk N, Baha A, et al. Comorbidities and their impact on chronic obstructive pulmonary disease. Tuberk. VE TORAK-Tuberk Toraks. 2016;64:289–298.
  • Lisspers K, Janson C, Larsson K, et al. Comorbidity and mortality in Swedish asthma patients 2006–2013—an observational register study (PACEHR). Eur Resp J. 2016;48:PA845.